BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23195732)

  • 1. Inhibition of the human deacylase Sirtuin 5 by the indole GW5074.
    Suenkel B; Fischer F; Steegborn C
    Bioorg Med Chem Lett; 2013 Jan; 23(1):143-6. PubMed ID: 23195732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5.
    Fiorentino F; Castiello C; Mai A; Rotili D
    J Med Chem; 2022 Jul; 65(14):9580-9606. PubMed ID: 35802779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirt5 deacylation activities show differential sensitivities to nicotinamide inhibition.
    Fischer F; Gertz M; Suenkel B; Lakshminarasimhan M; Schutkowski M; Steegborn C
    PLoS One; 2012; 7(9):e45098. PubMed ID: 23028781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of sirtuin 5 inhibitors by ultrafast microchip electrophoresis using nanoliter volume samples.
    Guetschow ED; Kumar S; Lombard DB; Kennedy RT
    Anal Bioanal Chem; 2016 Jan; 408(3):721-31. PubMed ID: 26635020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic Tripeptide-based Potent and Selective Human SIRT5 Inhibitors.
    Jiang Y; Zheng W
    Med Chem; 2020; 16(3):358-367. PubMed ID: 31161996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bicyclic intermediate structure provides insights into the desuccinylation mechanism of human sirtuin 5 (SIRT5).
    Zhou Y; Zhang H; He B; Du J; Lin H; Cerione RA; Hao Q
    J Biol Chem; 2012 Aug; 287(34):28307-14. PubMed ID: 22767592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery.
    Yang LL; Wang HL; Yan YH; Liu S; Yu ZJ; Huang MY; Luo Y; Zheng X; Yu Y; Li GB
    Eur J Med Chem; 2020 Apr; 192():112201. PubMed ID: 32163813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the Substrate Specificity-Defining Residues of Human SIRT5 in Modulating the Structural Stability and Inhibitory Features of the Enzyme.
    Yu J; Haldar M; Mallik S; Srivastava DK
    PLoS One; 2016; 11(3):e0152467. PubMed ID: 27023330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based discovery of new selective small-molecule sirtuin 5 inhibitors.
    Liu S; Ji S; Yu ZJ; Wang HL; Cheng X; Li WJ; Jing L; Yu Y; Chen Q; Yang LL; Li GB; Wu Y
    Chem Biol Drug Des; 2018 Jan; 91(1):257-268. PubMed ID: 28756638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology.
    Kumar S; Lombard DB
    Crit Rev Biochem Mol Biol; 2018 Jun; 53(3):311-334. PubMed ID: 29637793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function and regulation of the mitochondrial sirtuin isoform Sirt5 in Mammalia.
    Gertz M; Steegborn C
    Biochim Biophys Acta; 2010 Aug; 1804(8):1658-65. PubMed ID: 19766741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and Specific Activators for Mitochondrial Sirtuins Sirt3 and Sirt5.
    Suenkel B; Valente S; Zwergel C; Weiss S; Di Bello E; Fioravanti R; Aventaggiato M; Amorim JA; Garg N; Kumar S; Lombard DB; Hu T; Singh PK; Tafani M; Palmeira CM; Sinclair D; Mai A; Steegborn C
    J Med Chem; 2022 Oct; 65(20):14015-14031. PubMed ID: 36228194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of new human Sirtuin 5 inhibitors by mimicking glutaryl-lysine substrates.
    Yang F; Su H; Deng J; Mou L; Wang H; Li R; Dai QQ; Yan YH; Qian S; Wang Z; Li GB; Yang L
    Eur J Med Chem; 2021 Dec; 225():113803. PubMed ID: 34461505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A FRET-based assay for screening SIRT5 specific modulators.
    Li Y; Huang W; You L; Xie T; He B
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1671-1674. PubMed ID: 25818461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Continuous Assay for the Deacylase Sirtuin 5 and Other Deacetylases.
    Roessler C; Tüting C; Meleshin M; Steegborn C; Schutkowski M
    J Med Chem; 2015 Sep; 58(18):7217-23. PubMed ID: 26308971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin.
    Schuetz A; Min J; Antoshenko T; Wang CL; Allali-Hassani A; Dong A; Loppnau P; Vedadi M; Bochkarev A; Sternglanz R; Plotnikov AN
    Structure; 2007 Mar; 15(3):377-89. PubMed ID: 17355872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrates for efficient fluorometric screening employing the NAD-dependent sirtuin 5 lysine deacylase (KDAC) enzyme.
    Madsen AS; Olsen CA
    J Med Chem; 2012 Jun; 55(11):5582-90. PubMed ID: 22583019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and Selective Inhibitors of Human Sirtuin 5.
    Kalbas D; Liebscher S; Nowak T; Meleshin M; Pannek M; Popp C; Alhalabi Z; Bordusa F; Sippl W; Steegborn C; Schutkowski M
    J Med Chem; 2018 Mar; 61(6):2460-2471. PubMed ID: 29494161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-Based Inhibitors of the Human Sirtuin 5 Deacylase: Structure-Activity Relationship, Biostructural, and Kinetic Insight.
    Rajabi N; Auth M; Troelsen KR; Pannek M; Bhatt DP; Fontenas M; Hirschey MD; Steegborn C; Madsen AS; Olsen CA
    Angew Chem Int Ed Engl; 2017 Nov; 56(47):14836-14841. PubMed ID: 29044784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and Purification of Catalytically Active Recombinant Sirtuin5 (SIRT5) Protein.
    Kumar S; Lombard DB
    Methods Mol Biol; 2016; 1436():241-57. PubMed ID: 27246219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.